Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GLSI-100 |
Trade Name | |
Synonyms | GLSI 100|GLSI100 |
Drug Descriptions |
GLSI-100 comprises a peptide containing the ERBB2 (HER2)-derived epitope GP2 combined with Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF), which potentially induces an enhanced antitumor immune response against ERBB2 (HER2)-expressing tumor cells (Cancer Res (2023) 83 (5_Supplement): OT2-10-06). |
DrugClasses | HER2 (ERBB2) Vaccine 14 |
CAS Registry Number | NA |
NCIT ID | C187041 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GLSI-100 | GLSI-100 | 0 | 1 |